Top 50 corporate institutions in biomedical sciences

The table shows leading corporate institutions ranked by their fractional count (FC) in biomedical sciences from 2015 to 2018. Also listed are institution's total number of biomedical science articles in the Nature Index (AC 2015–2018) and the proportion of each institution's FC in biomedical sciences relative to total FC from 2015 to 2018 (biomedical sciences %).

Click on column headers to sort

RankInstitutionCountry / RegionFC 2015-
2018
AC 2015-
2018
Biomedical sciences (%)
1F. Hoffmann-La Roche AGSwitzerland156.8435878.7 %
2Novartis International AGSwitzerland104.6926880.5 %
3AstraZeneca plcUnited Kingdom (UK)71.2621867.1 %
4Pfizer Inc.United States of America (USA)52.5315757.5 %
5GlaxoSmithKline plc. (GSK)United Kingdom (UK)52.4319169.7 %
6Amgen Inc.United States of America (USA)51.2715375.3 %
7Merck & Co., Inc.United States of America (USA)41.0312135.9 %
8BGIChina29.6213495.5 %
9Johnson & JohnsonUnited States of America (USA)22.869464.7 %
10Eli Lilly and CompanyUnited States of America (USA)22.577864.1 %
11Formosa Plastics GroupTaiwan22.188876.6 %
12Regeneron Pharmaceuticals, Inc.United States of America (USA)20.685294.4 %
13Bristol-Myers Squibb (BMS)United States of America (USA)19.567439.0 %
14SanofiFrance19.087372.9 %
15Ionis Pharmaceuticals, Inc.United States of America (USA)15.417393.1 %
16Takeda Pharmaceutical Company LimitedJapan15.184276.8 %
17New England Biolabs, Inc. (NEB)United States of America (USA)14.353296.7 %
18Alphabet Inc.United States of America (USA)13.984831.2 %
19Biogen Inc.United States of America (USA)13.606091.8 %
20Novo Nordisk A/SDenmark13.374478.1 %
21AbbVie Inc.United States of America (USA)13.233964.3 %
22Illumina, Inc.United States of America (USA)12.157393.4 %
23IBM CorporationUnited States of America (USA)12.02466.3 %
24C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim)Germany9.013530.5 %
25Thermo Fisher Scientific Inc.United States of America (USA)8.206026.7 %
26Bayer AGGermany8.144460.3 %
27Human Longevity, Inc.United States of America (USA)7.841899.2 %
28Merck KGaAGermany7.603047.4 %
29Nestlé S.A.Switzerland7.273570.2 %
30UCB S.A.Belgium6.913354.4 %
31Gilead Sciences, Inc.United States of America (USA)6.772288.8 %
3223andMe, Inc.United States of America (USA)5.745092.0 %
33H3 Biomedicine Inc.United States of America (USA)5.6315100.0 %
34Pacific Biosciences of California, Inc.United States of America (USA)5.433289.6 %
35DowDuPont Inc.United States of America (USA)5.382310.7 %
36Seattle Genetics, Inc.United States of America (USA)5.03671.5 %
37Alnylam Pharmaceuticals, Inc.United States of America (USA)4.9815100.0 %
38Sosei Co., Ltd.Japan4.96897.8 %
39Synthetic Genomics, Inc. (SGI)United States of America (USA)4.707100.0 %
40Celgene CorporationUnited States of America (USA)4.5715100.0 %
41Momenta Pharmaceuticals, Inc.United States of America (USA)4.407100.0 %
42GeneDxUnited States of America (USA)4.2954100.0 %
43Constellation PharmaceuticalsUnited States of America (USA)4.199100.0 %
44Sangamo Therapeutics Inc.United States of America (USA)4.1410100.0 %
45Daiichi Sankyo Co., Ltd.Japan4.042667.6 %
46Nippon Telegraph and Telephone Corporation (NTT)Japan4.0186.7 %
47BASF SEGermany4.001512.4 %
48Genmab B.V.Netherlands3.89894.0 %
49Shimadzu CorporationJapan3.881346.8 %
50Austrian Centre of Industrial Biotechnology (ACIB)Austria3.841551.5 %